SCHEMBL25166704

SCHEMBL25166704

OCc1ccc2c(c1Br)OCCO2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 3/20 0.41
CD274 Q9NZQ7 3/20 0.41
MTNR1A P48039 6/20 0.36
HTT P42858 3/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 1/20 0.35
BLM P54132 1/20 0.35
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
NPC1 O15118 1/20 0.33
GAA P10253 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
KDM4E B2RXH2 2/20 0.33
NOTUM Q6P988 1/20 0.33
AOC3 Q16853 1/20 0.33
MAOB P27338 1/20 0.33
ITGB2 P05107 1/20 0.32
ICAM1 P05362 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25165979 0.87 AOC3 (0.44) PDCD1CD274ALDH1A1GAANOTUM
SCHEMBL20563280 0.78 CD274 (0.51) PDCD1CD274MTNR1AHTTALDH1A1
SCHEMBL26005665 0.75 ALOX5 (0.44) PDCD1CD274MTNR1AHTTLMNA
SCHEMBL19810492 0.74 HTR2C (0.40) PDCD1CD274MTNR1A
SCHEMBL21955275 0.73 AOC3 (0.31) PDCD1CD274AOC3
SCHEMBL2260257 0.73 MTNR1A (0.57) PDCD1CD274MTNR1AHTTLMNA
SCHEMBL25166334 0.71 LMNA (0.38) MTNR1AHTTLMNAMAPTBLM
SCHEMBL22827024 0.71 MAPT (0.38) MTNR1AHTTLMNAMAPTBLM
SCHEMBL25166705 0.71 HTT (0.38) MTNR1AHTTLMNAMAPTBLM
SCHEMBL30329793 0.71 LMNA (0.38) MTNR1AHTTLMNAMAPTBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368139-A1 NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF TANGO THERAPEUTICS, INC. 2024-11-07 US disclosed
CN-118647610-A Novel modulators of EHMT1 and EHMT2 and therapeutic uses thereof 探戈医药股份有限公司 2024-09-13 CN disclosed
WO-2023064586-A1 NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF TANGO THERAPEUTICS, INC. (US) 2023-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240368139-A1 NOVEL MODULATORS OF EHMT1 AND EHMT2 AND THERAPEUTIC USE THEREOF EHMT1, EHMT2, SHMT1 PDCD1 4216/4885CD274 4601/4885MTNR1A 1607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.